Download Files:
Vafidemstat
SKU
HY-112623-10 mg
Category Reference compound
Tags Epigenetics;Neuronal Signaling, Histone Demethylase;Monoamine Oxidase, Neurological Disease
$550 – $2,950
Products Details
Product Description
– Vafidemstat (ORY-2001) is an oral, brain penetrant, dual lysine-specific histone demethylase (LSD1)/MAO-B inhibitor[1].
Web ID
– HY-112623
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C19H20N4O2
References
– [1]ORYZON presents data on the Phase I trial with ORY-2001 at the 13th International Conference on Alzheimer’s and Parkinson’s diseases|[2]ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2018.
CAS Number
– 1357362-02-7
Molecular Weight
– 336.39
Compound Purity
– 99.53
SMILES
– NC1=NN=C(O1)CN[C@H]2[C@H](C3=CC=C(OCC4=CC=CC=C4)C=C3)C2
Clinical Information
– Phase 2
Research Area
– Neurological Disease
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Histone Demethylase;Monoamine Oxidase
Isoform
– KDM1/LSD1
Pathway
– Epigenetics;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.